Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Outcome comparisons of prior study of docetaxel + estramustine + ADT to the current study.
| Docetaxel + Estramustine + ADT9 (n=62) |
Docetaxel + Estramustine + ADT10 (n=62) |
Docetaxel + Bevacizumab + ADT (n=41) |
|
|---|---|---|---|
| Median follow-up | 37 months | 8.6 years | 27.5 months |
| PSA progression (%) | 53% | 77% | 80% |
| PSA complete response at one year following ADT completion (%) | 36% | 52%1 | 44% |
| TTP (months) | 33.8 | 35 | 28 |
11% had an undetectable PSA at long term follow-up.
